Insulet Corporation (PODD) Downgraded to Neutral by JP Morgan

Market Context

Insulet Corporation operates in the Healthcare sector. The stock currently trades at $139.30 with a market capitalization of $20.7B. The stock has declined 57.4% over the past 52 weeks.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow JP Morgan's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Insulet Corporation

Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 06, 2026	Leerink Partners	Market Perform	N/A
Aug 06, 2026	Benchmark	Buy	N/A
Aug 06, 2026	Bernstein	Outperform	N/A
Aug 06, 2026	RBC Capital	Outperform	N/A
Aug 06, 2026	UBS	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View PODD Stock Page